News

CMS: Medicare to Cover On-Label Use of Provenge


 

This coverage is provided courtesy of “The Pink Sheet.” “The Pink Sheet” and Internal Medicine News Digital Network are both owned by Elsevier.

Pages

Recommended Reading

Capecitabine May Protect Against Skin Cancers After Transplant
MDedge Family Medicine
Clinical Trial Participation Tied to Improved Breast Cancer Outcomes
MDedge Family Medicine
Gastric Cancer Can Recur Despite Response to Therapy
MDedge Family Medicine
FDA Panel Supports Device That Targets Brain Tumors
MDedge Family Medicine
More NCI Cooperative Groups Forming Alliances
MDedge Family Medicine
Thin Endometrial Echo Complex Does Not Rule Out Cancer
MDedge Family Medicine
NCCN Upgrades Rituximab Regimens for Follicular Lymphoma
MDedge Family Medicine
FDA: Ipilimumab Approved for Metastatic Melanoma
MDedge Family Medicine
Radiation From Backscatter X-Ray Scans Poses Little Cancer Risk
MDedge Family Medicine
Study Finds Few Second Cancers Attributable to Radiotherapy
MDedge Family Medicine